Fulgent Genetics Quote - FLGT

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

17.31

Bid

17.30

Offer

47.90

Volume

385,610

17.32 Day's Range 18.61

17.31 52 Week Range 30.68

Market Cap

524.436M

Previous Close

17.79

Open

17.90

Last Trade

17.45

Last Trade Time

Financial Volume

US$ 6,820,388

VWAP

17.6873

Average Volume (3m)

158,802

Shares Outstanding

30,296,682

Dividend Yield

PE Ratio

-3.13

Earnings Per Share (EPS)

-5.54

Revenue

289.21M

Net Profit

-167.83M

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and ... Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign. Show more

Sector

Medical Laboratories

Industry

Medical Laboratories

Website

www.fulgentgenetics.com

Headquarters

Dover, Delaware, USA

Founded

Fulgent Genetics Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker FLGT. The last closing price for Fulgent Genetics was US$17.79. Over the last year, Fulgent Genetics shares have traded in a share price range of US$ 17.31 to US$ 30.68.

Fulgent Genetics currently has 30,296,682 shares in issue. The market capitalisation of Fulgent Genetics is US$538.98 million. Fulgent Genetics has a price to earnings ratio (PE ratio) of -3.13.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Fulgent Reports Third Quarter 2024 Financial Results

Total Revenue of $71.7 million Core Revenue grows 9% year-over-year to $71.7 million Reiterates Full Year 2024 Core Revenue Guidance of $280 million, Improves Earnings Per Share Guidance for...

Fulgent to Participate in Upcoming Conferences

Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today...

Form 4 - Statement of changes in beneficial ownership of securities

Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-3.7	-17.6106615897	21.01	21.56	17.31	332309	18.99741965	CS
4	-2.45	-12.3987854251	19.76	22.87	17.31	221177	20.1019948	CS
12	-5.87	-25.3235547886	23.18	23.9868	17.31	158802	20.85521869	CS
26	-5.23	-23.2031943212	22.54	25.11	17.31	167384	21.43281023	CS
52	-10.11	-36.8708971554	27.42	30.68	17.31	183661	23.11849581	CS
156	-71.95	-80.6072148779	89.26	109.55	17.31	269016	44.89088304	CS
260	6.19	55.6654676259	11.12	189.8899	6.7	521457	58.99004533	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.17B
CYCNCyclerion Therapeutics Inc	US$ 2.5306 (42.97%)	11.99M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	165.69M
PULMPulmatrix Inc	US$ 6.5586 (39.54%)	5.37M
ZTEKZentek Ltd	US$ 1.2574 (29.96%)	309.67k
TFFPTFF Pharmaceuticals Inc	US$ 0.376101 (-76.49%)	9.35M
EYENEyenovia Inc	US$ 0.10185 (-70.05%)	52.8M
CTXRCitius Pharmaceuticals Inc	US$ 0.1974 (-39.89%)	11.26M
VVPRVivoPower International PLC	US$ 0.8151 (-39.62%)	2.34M
IPWiPower Inc	US$ 0.7302 (-39.15%)	1.15M
CEROCERo Therapeutics Holdings Inc	US$ 0.2853 (52.40%)	1.17B
ELABElevai Labs Inc	US$ 0.0211 (-19.47%)	380.03M
NVDANVIDIA Corporation	US$ 141.98 (-3.26%)	253.02M
SPPLSIMPPLE Ltd	US$ 1.2503 (41.60%)	165.69M
STISolidion Technology Inc	US$ 0.44 (25.71%)	140.02M